Hikma Pharmaceuticals Plc
(OTC) HKMPF
Hikma Pharmaceuticals Plc Financials at a Glance
Market Cap
$3.77B
Revenue (TTM)
$6.49B
Net Income (TTM)
$761.99M
EPS (TTM)
$1.82
P/E Ratio
9.50
Dividend
$1.32
Beta (Volatility)
0.28 (Low)
Dividend
$1.32
Beta (Volatility)
0.28 (Low)
Price
$16.82
Volume
172
Open
$16.82
Price
$16.82
Volume
172
Open
$16.82
Previous Close
$16.82
Daily Range
$16.82 - $16.82
52-Week Range
$16.34 - $27.96
Dividend
$1.32
Beta (Volatility)
0.28 (Low)
Price
$16.82
Volume
172
Open
$16.82
Previous Close
$16.82
Daily Range
$16.82 - $16.82
52-Week Range
$16.34 - $27.96
HKMPF News
HKMPF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hikma Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,400
CEO
Riad Mishlawi
Website
www.hikma.comHeadquarters
London, W1S 2HR, GB
HKMPF Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
17%
Net Income Margin
12%
Return on Equity
16%
Return on Capital
13%
Return on Assets
7%
Earnings Yield
10.53%
Dividend Yield
0.08%
Payout Ratio
45.16%
Stock Overview
Market Cap
$3.77B
Shares Outstanding
217.78M
Volume
172
Short Interest
0.00%
Avg. Volume
933.853
Financials (TTM)
Gross Profit
$1.37B
Operating Income
$637.88M
EBITDA
$854.59M
Operating Cash Flow
$366.98M
Capital Expenditure
$201.38M
Free Cash Flow
$165.60M
Cash & ST Invst.
$354.57M
Total Debt
$1.65B
Hikma Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.70B
+17.5%
Gross Profit
$674.05M
-2.6%
Gross Margin
39.62%
N/A
Market Cap
$3.77B
N/A
Market Cap/Employee
$396.47K
N/A
Employees
9,500
N/A
Net Income
$164.99M
+179.6%
EBITDA
$411.47M
+19.3%
Quarterly Fundamentals
Net Cash
$1.30B
-34.8%
Accounts Receivable
$1.08B
+37.0%
Inventory
$1.11B
+24.3%
Long Term Debt
$1.54B
+49.3%
Short Term Debt
$114.18M
-29.1%
Return on Assets
7.10%
N/A
Return on Invested Capital
13.38%
N/A
Free Cash Flow
$101.68M
-66.2%
Operating Cash Flow
$229.22M
-40.6%